The US-based institutional forex execution services and data analytics firm, Curex Group has announced the appointment of Glen Sargeant as Managing Director of European Business Development. His new role will be based out of company’s London office and will be responsible for developing customer relationship for Curex throughout the UK and Europe.
Glen Sargeant has more than two decades of experience in the global forex market. Earlier he was with Schroder Investment Management as Head of Foreign Exchange Trading for EMEA division, which he held for 19 years. He was responsible for large trading book that comprised of major and emerging market currencies. In his capacity, he overlooked optimisation of Fx trading processes through technology implementations while managing costs. He has also served as a Product manager, Buy side Fx at FlexTrade, focusing on the need of the buy side Fx community in the EMEA region.
Jamie Singleton, Cürex Group Chairman and Chief Executive Officer commented on Sargeant’s hire:
“We are thrilled to have Glen join our team. He brings a wealth of global business knowledge, meaningful institutional client relationships and a comprehensive understanding of the buy side’s need to adopt FX trading solutions and analytics that enable them to achieve best execution outcomes on behalf of their clients”
“We continue to grow our team as we enhance our product offerings for the buy side. Glen will be a significant asset for both our firm and our institutional clients.”
Glen Sargeant also commented on his appointment:
Cürex’s unique product and service offerings for the buy side are key motivators in my joining the company. I am delighted to be part of such a highly respected and innovative company whose trading and data analytics solutions are making a significant impact on the industry.
